Search

everythinglearnresearchcommunity

for

Search:↓

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

A man had a severe allergic reaction to sulfasalazine, with symptoms improving after treatment and follow-up.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

HPV does not cause aggressive cancer in RDEB patients.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Immune recovery after HIV treatment can cause autoimmune issues like hair loss and thyroid disease.

Beta-HPV and MCPyV are linked to certain skin cancers, with ongoing research and vaccine development.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Betulinic acid can help treat hepatitis C by stopping virus replication.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Herpes zoster can cause lasting nail and hair damage.

Early recognition and treatment of VATS in transplant patients improve outcomes.

CMV infection increases the risk of GvHD after bone marrow transplants.

A liver transplant patient with APECED had a rare VZV recurrence and pneumonia, treated successfully, but later died from other infections.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

Interferon therapy is a promising and safe treatment for hepatitis B in Southeast Asia.

A hepatitis B patient lost hair in patches after starting and stopping a treatment with pegylated interferon alpha2a.

A woman developed white patches on her skin and curly hair after hepatitis C treatment, likely due to the medication interferon alpha.

HLA can be linked to autoimmune hepatitis.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

34% of patients on hepatitis C treatment had reversible skin issues.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

HPV type 56 can hide in hair follicles even without visible warts.

COVID-19 vaccination is generally safe for people with Hidradenitis Suppurativa.

A 12-year-old boy had severe shingles and skin damage after a stem-cell transplant.